Blog - Page 40 of 5440 - QualityStocks

WednesdayAug 06, 2025 12:10 pm

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Subsidiary Starlight Therapeutics Cleared by FDA to Begin GBM Combination Trial

Lantern Pharma (NASDAQ: LTRN) announced that its wholly owned subsidiary, Starlight Therapeutics, has received FDA clearance for an Investigational New Drug (“IND”) application to initiate a Phase Ib/2a clinical trial of STAR-001 (LP-184) in combination with spironolactone for patients with glioblastoma multiforme (“GBM”) at first progression. The study will evaluate safety, tolerability and preliminary efficacy in recurrent GBM, a highly aggressive brain cancer with limited treatment options. STAR-001 is a brain-penetrant DNA-damaging agent designed to exploit DNA repair deficiencies through synthetic lethality, and its effect is enhanced by spironolactone, which induces NER deficiency in tumor cells. The therapy has received…

WednesdayAug 06, 2025 11:30 am

HeartBeam Inc. (NASDAQ: BEAT) FDA-Cleared System Provides Momentum as Company Moves to Innovate Cardiac Care

The FDA-cleared HeartBeam system enables patients and physicians to access significant arrhythmia data outside traditional clinical settings. The HeartBeam system, credit card–sized and fully portable, represents a breakthrough in ambulatory cardiac care. Beyond ambulatory arrhythmia assessment, the platform is poised for future advancements, including synthesized 12-lead ECG generation. Foundational clearance from the U.S. Food and Drug Administration (“FDA”) for its patented HeartBeam system has proved pivotal for HeartBeam (NASDAQ: BEAT), a cardiac technology company focused on transforming the cardiac-care space (https://ibn.fm/0TAG4). The first cable-free, high-fidelity ECG device that captures the heart’s electrical activity from three distinct directions, the HeartBeam system…

WednesdayAug 06, 2025 10:10 am

Bollinger Innovations Inc. (NASDAQ: BINI) Drives Commercial EV Leadership with Bold Rebrand, Market Clarity

Mullen Automotive recently brought all of its EV products and brands together under one strong and unified identity — Bollinger Innovations. The pivot to one commercial EV brand comes amid mounting demand for electrification in delivery, logistics and municipal vehicle fleets. The company’s new identity is also trading under new Nasdaq stock symbol NASDAQ: BINI. The company’s move under one brand clarifies market positioning, creating cohesion across product lines ready to service the commercial vehicle industry. Bollinger Innovations (NASDAQ: BINI), formerly known as Mullen Automotive, has completed a major corporate transformation, officially rebranding and switching its NASDAQ ticker from MULN to…

WednesdayAug 06, 2025 10:00 am

QualityStocksNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Offers $7,500 Price Cut on Mullen ONE and THREE EVs Ahead of Incentive Deadline

Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced $7,500 in additional price adjustments for commercial customers purchasing existing inventory of its Mullen ONE and Mullen THREE EVs. With MSRPs now set at $27,000 and $61,000 respectively, the incentive—combined with a $7,500 Inflation Reduction Act credit for deliveries before September 30—positions both models as high-value options in the Class 1 and Class 3 commercial EV segments. Formerly known as Mullen Automotive, the company recently rebranded and will relabel the vehicles under Bollinger Motors beginning in the 2026 model year. The product lineup also includes the Bollinger B4 Class 4 truck,…

WednesdayAug 06, 2025 9:50 am

Nutriband Inc. (NASDAQ: NTRB) Navigates Drug-Delivery Challenges with Innovation in Abuse-Deterrent Tech

Drug delivery plays a critical role in modern healthcare, but when it comes to potent opioids such as fentanyl, the stakes are particularly high Nutriband is developing Aversa(TM), a proprietary abuse-deterrent transdermal technology designed to prevent diversion, misuse, abuse and accidental exposure Nutriband’s Aversa(TM) fentanyl patch is estimated to have a market potential of $80 million to $200 million annually within five years of launch Developing safe, effective and abuse-deterrent delivery systems for controlled substances such as fentanyl is a formidable challenge, and Nutriband (NASDAQ: NTRB) is positioning itself at the forefront of that effort. The company is pioneering transdermal…

WednesdayAug 06, 2025 9:20 am

QualityStocksNewsBreaks – NextPlat Corp (NASDAQ: NXPL) to Report Q2 2025 Financial Results on August 14

NextPlat (NASDAQ: NXPL, NXPLW) a global provider of healthcare and technology solutions, will release its financial results for the quarter ended June 30, 2025, before market open on August 14. A conference call hosted by Interim CEO David Phipps and CFO Cecile Munnik will follow at 8:30 a.m. EDT to review the results and discuss recent developments. To view the full press release, visit: https://ibn.fm/BOgDL About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the company intends to assist businesses…

WednesdayAug 06, 2025 9:10 am

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Applauds FAA Proposal to Normalize BVLOS Drone Operations

Safe Pro Group (NASDAQ: SPAI), a leader in AI-powered defense and security solutions, welcomed the FAA’s proposed rules to streamline Beyond Visual Line of Sight (BVLOS) drone operations. The Company expects the move will accelerate adoption of its computer vision and object detection technologies across government, public, and commercial sectors. Safe Pro’s Airborne Response unit is a top provider of drone-based infrastructure inspections in Florida, and its AI technology has been field-tested in Ukraine to detect landmines and threats with high-speed accuracy. The Company is integrating these capabilities to expand services in public safety, disaster response, and environmental protection. To…

WednesdayAug 06, 2025 9:00 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Expands High-Grade Tin and Silver Zones at Iska Iska Project

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) announced assay results from the first five holes of its restarted definition drilling program in the Santa Barbara starter pit area at the Iska Iska silver-tin polymetallic project in Bolivia. The drilling highlights include 0.89% Sn over 16.5m and 0.90% Sn over 13.5m in hole DSB-78, along with 401.65 g/t Ag over 3.0m in hole DSB-79. All five holes intersected significant tin and silver mineralization, mostly hosted in intrusion breccias, with visible cassiterite likely amenable to gravity separation. Results confirm lateral and downdip continuity, supporting further infill and step-out drilling to expand…

TuesdayAug 05, 2025 12:25 pm

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Market Demand for Breast CT Imaging Innovation

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) emphasized the global trends driving demand for advanced breast cancer imaging technologies and the advantages of its IzoView Breast CT Imaging System. With over 2.3 million new cases of breast cancer diagnosed worldwide annually and U.S. incidence projected to exceed 315,000 in 2025, healthcare systems face growing pressure to improve screening outcomes. Market forecasts show global breast imaging revenues rising from $5.4 billion in 2024 to $8.69 billion by 2030. IzoView addresses clinical and patient needs with non-compressive 3D imaging, offering a more comfortable, accurate, and scalable alternative to conventional modalities—especially for the…

TuesdayAug 05, 2025 11:15 am

HeartBeam Inc.’s (NASDAQ: BEAT) Two New U.S. Patents Power Next Generation of Cardiac Diagnostics

Two newly issued patents mark a strategic advancement in HeartBeam’s proprietary technology. The first patent protects the company’s credit card–sized, cable-free 3D ECG device designed to capture high-fidelity electrical signals from three noncoplanar directions. The second patent covers the company’s rhythm analysis algorithm by continuously analyzing signal input. HeartBeam (NASDAQ: BEAT), a cardiac technology company, has secured two new U.S. patents that significantly enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology (https://ibn.fm/6xni4). The company, focused on delivering powerful, personalized insights into heart health through its innovative 3D ECG platform, now holds more than 20 U.S.…

Site Search

Company Search